168 related articles for article (PubMed ID: 24688597)
21. FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer.
Bassi MC; Turri L; Sacchetti G; Loi G; Cannillo B; La Mattina P; Brambilla M; Inglese E; Krengli M
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1423-6. PubMed ID: 17931795
[TBL] [Abstract][Full Text] [Related]
22. Cervical ultrasonography has no additional value over negative
Goense L; Meziani J; van Rossum PSN; Wessels FJ; Lam MGEH; van Hillegersberg R; Ruurda JP
Eur Radiol; 2018 May; 28(5):2031-2037. PubMed ID: 29218619
[TBL] [Abstract][Full Text] [Related]
23. Combined pretreatment with
Ji S; Hu Q; Zhu J; Chen J; Chen Q; Liu Z; Shen C; Yang R; Sun H; Wu J; Gu K
Trials; 2018 Aug; 19(1):416. PubMed ID: 30075736
[TBL] [Abstract][Full Text] [Related]
24. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
[TBL] [Abstract][Full Text] [Related]
25. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
[TBL] [Abstract][Full Text] [Related]
26. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
[TBL] [Abstract][Full Text] [Related]
27. Significant value of
Peng H; Chen L; Tang LL; Li WF; Mao YP; Guo R; Zhang Y; Liu LZ; Tian L; Zhang X; Lin XP; Guo Y; Sun Y; Ma J
Chin J Cancer; 2017 Dec; 36(1):95. PubMed ID: 29258597
[TBL] [Abstract][Full Text] [Related]
28. IMRT with ¹⁸FDG-PET\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer.
Cihoric N; Tapia C; Krüger K; Aebersold DM; Klaeser B; Lössl K
Radiat Oncol; 2014 Mar; 9():83. PubMed ID: 24661323
[TBL] [Abstract][Full Text] [Related]
29. Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy.
Leclerc M; Lartigau E; Lacornerie T; Daisne JF; Kramar A; Grégoire V
Radiother Oncol; 2015 Jul; 116(1):87-93. PubMed ID: 26088157
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer staging in a single session: whole-body PET/CT mammography.
Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G
J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
[TBL] [Abstract][Full Text] [Related]
31. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.
Heusch P; Buchbender C; Köhler J; Nensa F; Gauler T; Gomez B; Reis H; Stamatis G; Kühl H; Hartung V; Heusner TA
J Nucl Med; 2014 Mar; 55(3):373-8. PubMed ID: 24504054
[TBL] [Abstract][Full Text] [Related]
32.
van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
[TBL] [Abstract][Full Text] [Related]
33. Tumor volume delineation in head and neck cancer with 18-fluor-fluorodeoxiglucose positron emission tomography: adaptive thresholding method applied to primary tumors and metastatic lymph nodes.
Perez-Romasanta LA; Bellon-Guardia M; Torres-Donaire J; Lozano-Martin E; Sanz-Martin M; Velasco-Jimenez J
Clin Transl Oncol; 2013 Apr; 15(4):283-93. PubMed ID: 22865325
[TBL] [Abstract][Full Text] [Related]
34. Evaluating the Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Staging of Patients With Stage IIIB Cervical Carcinoma and the Impact on Treatment Decisions.
Morkel M; Ellmann A; Warwick J; Simonds H
Int J Gynecol Cancer; 2018 Feb; 28(2):379-384. PubMed ID: 29324535
[TBL] [Abstract][Full Text] [Related]
35. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.
Vanuytsel LJ; Vansteenkiste JF; Stroobants SG; De Leyn PR; De Wever W; Verbeken EK; Gatti GG; Huyskens DP; Kutcher GJ
Radiother Oncol; 2000 Jun; 55(3):317-24. PubMed ID: 10869746
[TBL] [Abstract][Full Text] [Related]
36. [
Adam JA; van Diepen PR; Mom CH; Stoker J; van Eck-Smit BLF; Bipat S
Gynecol Oncol; 2020 Nov; 159(2):588-596. PubMed ID: 32921477
[TBL] [Abstract][Full Text] [Related]
37. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
Kim HJ; Cho A; Yun M; Kim YT; Kang WJ
Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
[TBL] [Abstract][Full Text] [Related]
38. A feasibility study of 18F-fluorodeoxyglucose positron emission tomography targeting and simultaneous integrated boost for intensity-modulated radiosurgery and radiotherapy.
Solberg TD; Agazaryan N; Goss BW; Dahlbom M; Lee SP
J Neurosurg; 2004 Nov; 101 Suppl 3():381-9. PubMed ID: 15537193
[TBL] [Abstract][Full Text] [Related]
39. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181
[TBL] [Abstract][Full Text] [Related]
40. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]